Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lundgren

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Inflammatory Intestinal Diseases|June 14, 2021
Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational StudyHenrik Hovstadius, David Lundgren, Pontus Karling
Crohn'S & Colitis 360|February 13, 2023
Preclinical Markers in Inflammatory Bowel Disease. A Nested Case-Control StudyDavid Lundgren, Lovisa Widbom, Johan Hultdin, et al.
Gastroenterology Report|November 9, 2020
Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional studyJenny Pagoldh, David Lundgren, Ole B Suhr, et al.
Scandinavian Journal of Gastroenterology|January 25, 2019
Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopyDavid Lundgren, Vincy Eklöf, Richard Palmqvist, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 6, 2019
Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectinPontus Karling, David Lundgren, Vincy Eklöf, et al.
Lakartidningen|April 22, 2020
[Low diagnostic accuracy of rigid sigmoidoscopy in the investigation of rectal cancer]Marianne Wadman, Mårten Werner, David Lundgren, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatment
Ram Alaish, David Lundgren, Ole B Suhr, et al.
Therapeutic Advances in Gastroenterology|November 18, 2017
The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational studyAghil Ibrahim, Per Dahlqvist, Tommy Olsson, et al.
American Journal of Medical Genetics. Part A|February 14, 2006
A nonsense mutation of PEPD in four Amish children with prolidase deficiencyHeng Wang, Biji T Kurien, David Lundgren, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Inflammatory Intestinal Diseases|June 14, 2021
Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational StudyHenrik Hovstadius, David Lundgren, Pontus Karling
Crohn'S & Colitis 360|February 13, 2023
Preclinical Markers in Inflammatory Bowel Disease. A Nested Case-Control StudyDavid Lundgren, Lovisa Widbom, Johan Hultdin, et al.
Gastroenterology Report|November 9, 2020
Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional studyJenny Pagoldh, David Lundgren, Ole B Suhr, et al.
Scandinavian Journal of Gastroenterology|January 25, 2019
Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopyDavid Lundgren, Vincy Eklöf, Richard Palmqvist, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 6, 2019
Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectinPontus Karling, David Lundgren, Vincy Eklöf, et al.
Lakartidningen|April 22, 2020
[Low diagnostic accuracy of rigid sigmoidoscopy in the investigation of rectal cancer]Marianne Wadman, Mårten Werner, David Lundgren, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 14, 2017
Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatment
Ram Alaish, David Lundgren, Ole B Suhr, et al.
Therapeutic Advances in Gastroenterology|November 18, 2017
The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational studyAghil Ibrahim, Per Dahlqvist, Tommy Olsson, et al.
American Journal of Medical Genetics. Part A|February 14, 2006
A nonsense mutation of PEPD in four Amish children with prolidase deficiencyHeng Wang, Biji T Kurien, David Lundgren, et al.
Pageof 1